These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9065325)

  • 41. Imaging of mild cognitive impairment and early dementia.
    Schuff N; Zhu XP
    Br J Radiol; 2007 Dec; 80 Spec No 2():S109-14. PubMed ID: 18445740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The value of new diagnostic techniques in Alzheimer's disease].
    Scheltens P; Weinstein HC; van Gool WA
    Ned Tijdschr Geneeskd; 1992 Dec; 136(50):2459-62. PubMed ID: 1465167
    [No Abstract]   [Full Text] [Related]  

  • 43. Functional imaging in dementia: an overview.
    Jagust WJ
    J Clin Psychiatry; 1994 Nov; 55 Suppl():5-11. PubMed ID: 7989292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 45. [Interest and role of brain scintigraphy in the diagnosis of dementia in 2014].
    Habert MO; Bera G; Yeni N; Kas A
    Geriatr Psychol Neuropsychiatr Vieil; 2014 Dec; 12(4):413-23. PubMed ID: 25515906
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroimaging in child and adolescent psychiatry.
    Kuperman S; Gaffney GR; Hamdan-Allen G; Preston DF; Venkatesh L
    J Am Acad Child Adolesc Psychiatry; 1990 Mar; 29(2):159-72. PubMed ID: 2182609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Frontal lobe dementia--two cases diagnosed by SPECT].
    Namikawa T
    No To Shinkei; 1993 Dec; 45(12):1155-9. PubMed ID: 8123306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
    Johnson KA; Holman BL; Rosen TJ; Nagel JS; English RJ; Growdon JH
    Arch Intern Med; 1990 Apr; 150(4):752-6. PubMed ID: 2327836
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
    Cohen VI; Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Reba RC
    J Mol Neurosci; 1998 Aug; 11(1):1-9. PubMed ID: 9826782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ¹²³I-NKJ64: a novel single photon emission computed tomography radiotracer for imaging the noradrenaline transporter in brain.
    Tavares AA; Jobson NK; Dewar D; Sutherland A; Pimlott SL
    Synapse; 2011 Jul; 65(7):658-67. PubMed ID: 21157929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positron emission tomography in dementia.
    Santens P; Petit H
    Acta Neurol Belg; 1997 Sep; 97(3):192-5. PubMed ID: 9345592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear medicine imaging in dementia: a practical overview for hospitalists.
    Toney LK; McCue TJ; Minoshima S; Lewis DH
    Hosp Pract (1995); 2011 Aug; 39(3):149-60. PubMed ID: 21881402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Novel neuroimaging perspectives in the diagnosis of dementia].
    Jessen F
    Nervenarzt; 2008 Nov; 79 Suppl 3():129-36; quiz 137. PubMed ID: 18830576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-photon emission computed tomography (SPECT). Applications and potential.
    Holman BL; Tumeh SS
    JAMA; 1990 Jan; 263(4):561-4. PubMed ID: 2403612
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New approaches to imaging based on effects of neurotoxins.
    Francis PT; Chessell IP; Bowen DM
    Dement Geriatr Cogn Disord; 1997; 8(2):117-22. PubMed ID: 9065325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An aspect of Alzheimer neuropathology after suicide transport damage.
    Chessell IP; Francis PT; Webster MT; Procter AW; Heath PR; Pearson RC; Bowen DM
    J Neural Transm Suppl; 1994; 44():231-43. PubMed ID: 7897395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Localisation of muscarinic (m1) and other neurotransmitter receptors on corticofugal-projecting pyramidal neurones.
    Chessell IP; Francis PT; Pangalos MN; Pearson RC; Bowen DM
    Brain Res; 1993 Dec; 632(1-2):86-94. PubMed ID: 8149248
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin.
    Francis PT; Pangalos MN; Pearson RC; Middlemiss DN; Stratmann GC; Bowen DM
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1273-81. PubMed ID: 1534843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroimaging for diagnosis of dementia.
    Small GW; Leiter F
    J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.